SCHEMBL21054355

SCHEMBL21054355

COC(=O)Cc1cc(Br)sc1Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 1/20 0.42
HTT P42858 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TSHR P16473 2/20 0.37
KAT2B Q92831 1/20 0.36
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 3/20 0.36
GAA P10253 2/20 0.36
GLA P06280 2/20 0.36
EGFR P00533 1/20 0.36
PDGFRB P09619 1/20 0.36
FGFR1 P11362 1/20 0.36
PDGFRA P16234 1/20 0.36
FLT1 P17948 1/20 0.36
FGFR3 P22607 1/20 0.36
KDR P35968 1/20 0.36
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
HPGD P15428 3/20 0.36
GFER P55789 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14645332 0.86 HSP90AB1 (0.42) HSP90AB1HTTHSD17B10TSHRKAT2B
SCHEMBL7072235 0.84 TSHR (0.40) HTTHSD17B10TSHRKAT2BALDH1A1
SCHEMBL350771 0.83 SMN1; SMN2 (0.42) HTTTSHRKAT2BALDH1A1EGFR
SCHEMBL14646005 0.80 MAPT (0.46) HSP90AB1HTTHSD17B10ALDH1A1KDM4E
SCHEMBL19268668 0.79 CYP3A4 (0.40) LMNAMAPTL3MBTL1
SCHEMBL14645328 0.79 HSP90AB1 (0.37) HSP90AB1HTTHSD17B10ALDH1A1KDM4E
SCHEMBL365715 0.77 AKR1B1 (0.38) HTTHSD17B10ALDH1A1MAPTKMT2A
SCHEMBL15695235 0.77 MAPT (0.46) HSP90AB1HTTHSD17B10ALDH1A1KDM4E
SCHEMBL14645396 0.77 HPGD (0.40) HSP90AB1HTTHSD17B10ALDH1A1KDM4E
SCHEMBL15695223 0.76 MAPT (0.35) HSP90AB1HTTHSD17B10ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11713371-B2 Polar functional group-partially introduced polymer, preparation method therefor, and organic electronic element containing same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2023-08-01 US disclosed
US-11713371-B2 Polar functional group-partially introduced polymer, preparation method therefor, and organic electronic element containing same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2023-08-01 US disclosed
US-11713371-B2 Polar functional group-partially introduced polymer, preparation method therefor, and organic electronic element containing same KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2023-08-01 US disclosed
US-20220267300-A1 SULFONAMIDE DERIVATIVES AND USES THEREOF NodThera Limited (GB) 2022-08-25 US disclosed
CN-114761383-A Sulfonamide derivatives and uses thereof 诺瑟拉有限公司 2022-07-15 CN disclosed
EP-3983388-A1 SULFONAMIDE DERIVATIVES AND USES THEREOF Nodthera Limited (GB) 2022-04-20 EP disclosed
WO-2020249669-A1 SULFONAMIDE DERIVATIVES AND USES THEREOF NodThera Limited (GB) 2020-12-17 WO disclosed
WO-2020249669-A1 SULFONAMIDE DERIVATIVES AND USES THEREOF NodThera Limited (GB) 2020-12-17 WO disclosed
US-20200308342-A1 POLAR FUNCTIONAL GROUP-PARTIALLY INTRODUCED POLYMER, PREPARATION METHOD THEREFOR, AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2020-10-01 US disclosed
WO-2019112220-A1 POLAR FUNCTIONAL GROUP-PARTIALLY INTRODUCED POLYMER, PREPARATION METHOD THEREFOR, AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME 한국화학연구원 2019-06-13 WO disclosed
WO-2019112220-A1 POLAR FUNCTIONAL GROUP-PARTIALLY INTRODUCED POLYMER, PREPARATION METHOD THEREFOR, AND ORGANIC ELECTRONIC ELEMENT CONTAINING SAME 한국화학연구원 2019-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220267300-A1 SULFONAMIDE DERIVATIVES AND USES THEREOF IL1B, IL1A, CASP1 HSP90AB1 1336/4885HTT 4669/4885HSD17B10 2145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.